Cargando…
Evaluation of fibromyalgia syndrome in patients with rosacea
OBJECTIVES: This study aims to investigate the frequency of fibromyalgia syndrome (FMS) in rosacea patients and the relationship between disease disability score of FMS and quality of life score of rosacea. PATIENTS AND METHODS: This cross-sectional controlled clinical trial was performed between De...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Turkish League Against Rheumatism
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8418776/ https://www.ncbi.nlm.nih.gov/pubmed/34527930 http://dx.doi.org/10.46497/ArchRheumatol.2021.8280 |
_version_ | 1783748632547164160 |
---|---|
author | ACAR, Emine Müge KAYA ERDOĞAN, Hilal ŞAŞ, Senem ACER, Ersoy |
author_facet | ACAR, Emine Müge KAYA ERDOĞAN, Hilal ŞAŞ, Senem ACER, Ersoy |
author_sort | ACAR, Emine Müge |
collection | PubMed |
description | OBJECTIVES: This study aims to investigate the frequency of fibromyalgia syndrome (FMS) in rosacea patients and the relationship between disease disability score of FMS and quality of life score of rosacea. PATIENTS AND METHODS: This cross-sectional controlled clinical trial was performed between December 2017 and December 2018. One hundred female rosacea patients (mean age 43.2±10.1; range, 21 to 65 years) and 100 age- and sex-matched control subjects (mean age 41.2±11.1; range, 22 to 68 years) with no history of skin disease and systemic diseases including diabetes, cardiovascular, renal and hepatic diseases were recruited. Dermatology Life Quality Index (DLQI) scores were calculated using a 10-item self-administered questionnaire. The diagnosis of FMS was established according to 2010 American College of Rheumatology diagnostic criteria. Fibromyalgia Impact Questionnaire (FIQ) was used to determine the clinical severity and functional disability, while Visual Analog Scale (VAS) was used to determine pain severity in the patients with FMS. RESULTS: The frequency of FMS in patient group was significantly higher than control group (p=0.019). The mean duration of FMS in patient group was significantly higher than control group (p=0.001). There was no significant difference in terms of the age of onset of FMS, FIQ and VAS scores between groups (p=0.53, p=0.54, p=0.07, respectively). DLQI scores were significantly correlated with FIQ scores in the patient group (r=0.43, p=0.008). CONCLUSION: The frequency of FMS in rosacea patients was significantly higher than control subjects without any skin disease and there was a correlation between disability score of FMS and quality of life score of rosacea. Investigating fibromyalgia symptoms in rosacea patients may be helpful for providing patient-based therapeutic approaches where neurologically based treatments may also be beneficial for rosacea. |
format | Online Article Text |
id | pubmed-8418776 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Turkish League Against Rheumatism |
record_format | MEDLINE/PubMed |
spelling | pubmed-84187762021-09-14 Evaluation of fibromyalgia syndrome in patients with rosacea ACAR, Emine Müge KAYA ERDOĞAN, Hilal ŞAŞ, Senem ACER, Ersoy Arch Rheumatol Original Article OBJECTIVES: This study aims to investigate the frequency of fibromyalgia syndrome (FMS) in rosacea patients and the relationship between disease disability score of FMS and quality of life score of rosacea. PATIENTS AND METHODS: This cross-sectional controlled clinical trial was performed between December 2017 and December 2018. One hundred female rosacea patients (mean age 43.2±10.1; range, 21 to 65 years) and 100 age- and sex-matched control subjects (mean age 41.2±11.1; range, 22 to 68 years) with no history of skin disease and systemic diseases including diabetes, cardiovascular, renal and hepatic diseases were recruited. Dermatology Life Quality Index (DLQI) scores were calculated using a 10-item self-administered questionnaire. The diagnosis of FMS was established according to 2010 American College of Rheumatology diagnostic criteria. Fibromyalgia Impact Questionnaire (FIQ) was used to determine the clinical severity and functional disability, while Visual Analog Scale (VAS) was used to determine pain severity in the patients with FMS. RESULTS: The frequency of FMS in patient group was significantly higher than control group (p=0.019). The mean duration of FMS in patient group was significantly higher than control group (p=0.001). There was no significant difference in terms of the age of onset of FMS, FIQ and VAS scores between groups (p=0.53, p=0.54, p=0.07, respectively). DLQI scores were significantly correlated with FIQ scores in the patient group (r=0.43, p=0.008). CONCLUSION: The frequency of FMS in rosacea patients was significantly higher than control subjects without any skin disease and there was a correlation between disability score of FMS and quality of life score of rosacea. Investigating fibromyalgia symptoms in rosacea patients may be helpful for providing patient-based therapeutic approaches where neurologically based treatments may also be beneficial for rosacea. Turkish League Against Rheumatism 2021-01-14 /pmc/articles/PMC8418776/ /pubmed/34527930 http://dx.doi.org/10.46497/ArchRheumatol.2021.8280 Text en Copyright © 2021, Turkish League Against Rheumatism https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Original Article ACAR, Emine Müge KAYA ERDOĞAN, Hilal ŞAŞ, Senem ACER, Ersoy Evaluation of fibromyalgia syndrome in patients with rosacea |
title | Evaluation of fibromyalgia syndrome in patients with rosacea |
title_full | Evaluation of fibromyalgia syndrome in patients with rosacea |
title_fullStr | Evaluation of fibromyalgia syndrome in patients with rosacea |
title_full_unstemmed | Evaluation of fibromyalgia syndrome in patients with rosacea |
title_short | Evaluation of fibromyalgia syndrome in patients with rosacea |
title_sort | evaluation of fibromyalgia syndrome in patients with rosacea |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8418776/ https://www.ncbi.nlm.nih.gov/pubmed/34527930 http://dx.doi.org/10.46497/ArchRheumatol.2021.8280 |
work_keys_str_mv | AT acareminemuge evaluationoffibromyalgiasyndromeinpatientswithrosacea AT kayaerdoganhilal evaluationoffibromyalgiasyndromeinpatientswithrosacea AT sassenem evaluationoffibromyalgiasyndromeinpatientswithrosacea AT acerersoy evaluationoffibromyalgiasyndromeinpatientswithrosacea |